These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 29382075)

  • 1. Systematic Structure-Activity Relationship (SAR) Exploration of Diarylmethane Backbone and Discovery of A Highly Potent Novel Uric Acid Transporter 1 (URAT1) Inhibitor.
    Cai W; Wu J; Liu W; Xie Y; Liu Y; Zhang S; Xu W; Tang L; Wang J; Zhao G
    Molecules; 2018 Jan; 23(2):. PubMed ID: 29382075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Flexible Naphthyltriazolylmethane-based Thioacetic Acids as Highly Active Uric Acid Transporter 1 (URAT1) Inhibitors for the Treatment of Hyperuricemia of Gout.
    Zhang X; Wu J; Liu W; Liu Y; Xie Y; Shang Q; Zhou Z; Xu W; Tang L; Wang J; Zhao G
    Med Chem; 2017; 13(3):260-281. PubMed ID: 27633583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a Flexible Triazolylbutanoic Acid as a Highly Potent Uric Acid Transporter 1 (URAT1) Inhibitor.
    Tian H; Liu W; Zhou Z; Shang Q; Liu Y; Xie Y; Liu C; Xu W; Tang L; Wang J; Zhao G
    Molecules; 2016 Nov; 21(11):. PubMed ID: 27854343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Stereoselective Metabolism, Inhibitory Effect on Uric Acid Uptake Transporters, and Pharmacokinetics of Lesinurad Atropisomers.
    Yang C; Zhou D; Shen Z; Wilson DM; Renner M; Miner JN; Girardet JL; Lee CA
    Drug Metab Dispos; 2019 Feb; 47(2):104-113. PubMed ID: 30442650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stronger Uricosuric Effects of the Novel Selective URAT1 Inhibitor UR-1102 Lowered Plasma Urate in Tufted Capuchin Monkeys to a Greater Extent than Benzbromarone.
    Ahn SO; Ohtomo S; Kiyokawa J; Nakagawa T; Yamane M; Lee KJ; Kim KH; Kim BH; Tanaka J; Kawabe Y; Horiba N
    J Pharmacol Exp Ther; 2016 Apr; 357(1):157-66. PubMed ID: 26907620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and characterization of verinurad, a potent and specific inhibitor of URAT1 for the treatment of hyperuricemia and gout.
    Tan PK; Liu S; Gunic E; Miner JN
    Sci Rep; 2017 Apr; 7(1):665. PubMed ID: 28386072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, biological evaluation and 3D-QSAR studies of 1,2,4-triazole-5-substituted carboxylic acid bioisosteres as uric acid transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia associated with gout.
    Wu JW; Yin L; Liu YQ; Zhang H; Xie YF; Wang RL; Zhao GL
    Bioorg Med Chem Lett; 2019 Feb; 29(3):383-388. PubMed ID: 30579795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Human Urate Transporter 1 Inhibitors as Hypouricemic Drug Candidates with Favorable Druggability.
    Zhao T; Meng Q; Sun Z; Chen Y; Ai W; Zhao Z; Kang D; Dong Y; Liang R; Wu T; Pang J; Liu X; Zhan P
    J Med Chem; 2020 Oct; 63(19):10829-10854. PubMed ID: 32897699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney.
    Miner JN; Tan PK; Hyndman D; Liu S; Iverson C; Nanavati P; Hagerty DT; Manhard K; Shen Z; Girardet JL; Yeh LT; Terkeltaub R; Quart B
    Arthritis Res Ther; 2016 Oct; 18(1):214. PubMed ID: 27716403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological Evaluation of Dotinurad, a Selective Urate Reabsorption Inhibitor.
    Taniguchi T; Ashizawa N; Matsumoto K; Saito R; Motoki K; Sakai M; Chikamatsu N; Hagihara C; Hashiba M; Iwanaga T
    J Pharmacol Exp Ther; 2019 Oct; 371(1):162-170. PubMed ID: 31371478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of novel benzbromarone derivatives designed to avoid metabolic activation.
    Ohe T; Umezawa R; Kitagawara Y; Yasuda D; Takahashi K; Nakamura S; Abe A; Sekine S; Ito K; Okunushi K; Morio H; Furihata T; Anzai N; Mashino T
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3708-3711. PubMed ID: 30389287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel benzbromarone analogs with improved pharmacokinetics and benign toxicity profiles as antihyperuricemic agents.
    Zhao Z; Liu J; Yuan L; Yang Z; Kuang P; Liao H; Luo J; Feng H; Zheng F; Chen Y; Wu T; Guo J; Cao Y; Yang Y; Lin C; Zhang Q; Chen J; Pang J
    Eur J Med Chem; 2022 Nov; 242():114682. PubMed ID: 36001935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological evaluation of 3-phenyl substituted pyridine derivatives as potential dual inhibitors of XOR and URAT1.
    Yang C; Cai H; Zhu X; Zhang L; Li J
    Eur J Med Chem; 2024 May; 271():116407. PubMed ID: 38663283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDER167, a dual inhibitor of URAT1 and GLUT9, is a novel and potent uricosuric candidate for the treatment of hyperuricemia.
    Zhao ZA; Jiang Y; Chen YY; Wu T; Lan QS; Li YM; Li L; Yang Y; Lin CT; Cao Y; Zhou PZ; Guo JY; Tian YX; Pang JX
    Acta Pharmacol Sin; 2022 Jan; 43(1):121-132. PubMed ID: 33767379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of a potent and selective inhibitor of human urate transporter 1.
    Wu T; Chen J; Dong S; Li H; Cao Y; Tian Y; Fu W; Zhou P; Xi B; Pang J
    Pharmacol Rep; 2017 Oct; 69(5):1103-1112. PubMed ID: 28988709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of Novel Biphenyl Carboxylic Acid Derivatives as Potent URAT1 Inhibitors.
    Hou X; Wang Y; Yang Y; Xiao Z
    Molecules; 2023 Nov; 28(21):. PubMed ID: 37959834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological studies of dual URAT1 inhibitor and FXR agonist based on benzbromarone.
    Huang W; Jiao S; Chen S; Chen Y; Yang Z; Wang W; Cao Z; Li Z; Zhang L
    Bioorg Med Chem; 2022 Dec; 75():117073. PubMed ID: 36347120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of digallic acid as XOD/URAT1 dual target inhibitor for the treatment of hyperuricemia.
    Zheng F; Mai S; Cen X; Zhao P; Ye W; Ke J; Lin S; Hu H; Guo Z; Zhang S; Liao H; Wu T; Tian Y; Zhang Q; Pang J; Zhao Z
    Bioorg Chem; 2024 Jun; 147():107381. PubMed ID: 38669781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2016-2019).
    Dong Y; Zhao T; Ai W; Zalloum WA; Kang D; Wu T; Liu X; Zhan P
    Expert Opin Ther Pat; 2019 Nov; 29(11):871-879. PubMed ID: 31593642
    [No Abstract]   [Full Text] [Related]  

  • 20. [Molecular mechanism in biological transport in the kidney: Urate transporter URAT1].
    Hosoyamada M; Shibasaki T; Ichida K
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():176-9. PubMed ID: 16523883
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.